Clinical Trials Browser

Phase 3 × INDUSTRY × icotinib × Clear all

NCT06041776 2023-09-22

Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT02448797 2021-07-20

EVIDENCE

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT04058704 2019-08-15

SMART

Phase 3 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT02125240 2018-07-16

ICWIP

Phase 3 Unknown

Adenocarcinoma

NCT02486354 2015-07-01

Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung

NCT01040780 2014-02-14

ICOGEN

Phase 3 Completed

399 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung